SAN DIEGO, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders, today announced it will release financial results for the third quarter ended September 30, 2014, after the market closes on Thursday November 6, 2014, and will hold a conference call on this day at 4:30 p.m. ET (1:30 p.m. PT), to discuss these financial results and provide a company update.
To access the live webcast please visit the Company's Investor Relations website at ir.zogenix.com, and to participate, please dial 877-417-5253 (U.S.) or 315-625-3082 (International); participant passcode: 18407877.
The conference call will be hosted by Chief Executive Officer Roger L. Hawley, President Stephen J. Farr, Ph.D., and Executive Vice President and Chief Financial Officer Ann Rhoads.
A replay of the conference call will be available beginning November 6, 2014 at 7:30 p.m. ET (4:30 p.m. PT) until November 13, 2014, by dialing 855-859-2056 (U.S.) or 404-537-3406 (International); passcode: 18407877. A replay of the webcast will also be accessible on the Investor Relations website for one month, through December 6, 2014.
About Zogenix
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with pain-related conditions and CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.
FPR